You just read:

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

News provided by

DelMar Pharmaceuticals, Inc.

25 Apr, 2017, 08:30 ET